Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jaime Rubio-Perez"'
Autor:
Jaime Rubio-Perez, Ángel Ricardo Rodríguez-Perez, María Díaz-Blázquez, Victor Moreno-García, Manuel Dómine-Gómez
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-7 (2022)
Abstract Background Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymph
Externí odkaz:
https://doaj.org/article/2bdbdec0bb4d4f0ca971f418047aa2f4
Autor:
Jaime Rubio-Perez, Ángel Ricardo Rodríguez-Perez, María Díaz-Blázquez, Victor Moreno-García, Manuel Dómine-Gómez
Publikováno v:
Journal of medical case reports. 16(1)
Background Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymphohistiocy
Autor:
Grace Shaw, Pier Vitale Nuzzo, Edoardo Francini, Pietro Rosellini, Celestia S. Higano, Miguel Gonzalez-Velez, Irene Moreno-Candilejo, Francesca Crivelli, Antonio Cigliola, Richard M. Lee-Ying, Guido Francini, Lauren C. Harshman, Christopher Sweeney, Francesco Montagnani, Jesus Garcia-Foncillas, Alan H. Bryce, Jaime Rubio-Perez, Li Zhang, Roberto Petrioli, Nimira S. Alimohamed, Daniel Y.C. Heng, Carmelo Bengala
Publikováno v:
JAMA Network Open
Key Points Question Do patients receiving abiraterone acetate with prednisone as first-line therapy for the treatment of metastatic castration-resistant prostate cancer with bone metastases benefit from the addition of bone resorption inhibitors? Fin
Autor:
Yolanda Lage, Jaime Rubio Perez, Eva Ruiz, Tatiana Hernandez, Jesús García-Foncillas, Victor Moreno, Ana Belen Ruperez, Bernard Doger, Roberto Sosa Hernández
Publikováno v:
Archives of Clinical and Medical Case Reports.
Background: The use of novel agents such as checkpoint inhibitors and the combination with targeted therapies has been increasing exponentially in the last years. Because of this the toxicity profile has been changed and uncommon syndromes are more f